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Abstract: The growing interest in potential health effects of long-chain polyunsaturated fatty
acids (PUFAs) makes it important to evaluate the method used to assess the fatty acid intake
in nutrition research studies. We aimed to validate the questionnaire-based dietary intake of
selected PUFAs: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), α-linolenic acid (ALA),
linoleic acid (LA), and arachidonic acid (AA) within the Danish National Birth Cohort (DNBC),
by comparing 345 women’s reported intake with concentration of plasma biomarkers. The applied
questionnaire- and biomarker data reflect dietary intake from around the same time point in
mid-pregnancy and relationships were investigated by use of Pearson and Spearman correlation and
linear regression statistics. We demonstrated moderate but consistent adjusted correlations between
dietary intake estimates and the corresponding plasma biomarker concentrations (differences in
plasma concentration per 100 mg/day greater intake of 0.05 (95% CI: 0.02; 0.08)) and 0.05 (95% CI:
0.01; 0.08) percentage of total plasma fatty acids for EPA and DHA, respectively). The associations
strengthened when restricting the analyses to women with ALA intake below the median intake.
We found a weak correlation between the dietary intake of ALA and its plasma biomarker with a
difference in plasma concentration of 0.07 (95% CI: 0.03; 0.10) percent of total plasma fatty acids
per 1 g/day greater intake, while the dietary intake of LA and AA did not correlate with their
corresponding biomarkers.
Keywords: long-chained n-3 fatty acids; LCn3FAs; polyunsaturated fatty acid; PUFAs; food frequency
questionnaire; FFQ; validation study; biomarkers; Danish National Birth Cohort; pregnancy diet
1. Introduction
Polyunsaturated fatty acids (PUFAs) are commonly perceived as health-promoting dietary
components [1]. Particularly, the seafood-specific PUFAs, eicosapentaenoic acid (EPA), and
docosahexaenoic acid (DHA), belonging to the essential long-chained n-3 (LCn3FAs) family, have
been investigated thoroughly in the attempt to understand their putative beneficial roles in
pregnancy-related complications, developmental outcomes, as well as non-communicable diseases in
adulthood [2–6]. This particular interest in dietary PUFAs makes it important to evaluate the various
methods used in nutrition research to estimate fatty acid intake, since a poor estimate might lead to
Nutrients 2019, 11, 568; doi:10.3390/nu11030568 www.mdpi.com/journal/nutrients
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distorted associations between health and disease endpoints, and consequently inadequate dietary
recommendations based on the false or imprecise findings.
Self-reported dietary intake is a commonly employed measure in epidemiological studies, and has
a high utility, such as in relation to establishing dietary recommendations. However, estimates based
on self-reporting are often afflicted by lack of precision in the reporting and are curtailed by the
methods used for nutrient calculations, which often have to rely on quite rough assumptions related to
standard recipes, portion sizes, and food compositions [7].
Plasma EPA and DHA concentrations are already recognized as specific and robust biomarkers of
EPA and DHA status and intake as indicated by strong correlations with dietary intake estimates [8,9].
Other commonly addressed PUFAs in diet–disease association studies include α-linolenic acid (ALA),
linoleic acid (LA), and arachidonic acid (AA). Some studies show moderate to strong correlations
between intakes of LA and ALA and their plasma biomarkers [10–12]; however, overall, plasma levels
of ALA, LA, and AA tend to show much weaker correlations with estimated dietary intake compared
with EPA and DHA [11,13–15]. Whether the poor correlations are caused by imprecision in intake
quantification or inconsistency between actual dietary intake and plasma levels due to endogenous
processes is not completely understood.
The food frequency questionnaire (FFQ) applied in the large Danish National Birth Cohort
(DNBC) has previously been validated in a subsample of 88 women against 7-day weighted food
diaries and blood biomarkers of LCn3FAs [16]. The results demonstrated a moderate correlation
between FFQ-based intake estimates of total LCn3FAs and EPA levels in erythrocyte membranes
(r = 0.37, p = 0.001) [16]. In the present study, we had an opportunity to explore the relationship in a
bigger subsample of the DNBC (345 vs. 88 women in the earlier study), for a wider range of fatty acids,
and with a more optimal design for studying the relationship between self-reported dietary intake
and biomarkers.
To justify the use of FFQ-derived estimates of long chained PUFA intake in the Danish National
Birth Cohort (DNBC) in future diet–disease association studies, the aim of the present study was to
validate the FFQ-based intake estimates of EPA and DHA and investigate—in a more exploratory
manner—the relationship between ALA, LA, and AA intake and their respective biomarkers.
2. Materials and Methods
2.1. The Cohort Database
The DNBC was established in the period of 1996–2002 and included approximately
100,000 pregnancies in Denmark. All participating women gave consent on behalf of themselves
and their children to participate in interviews and questionnaires, giving blood samples, register
linkages, and other types of follow-up (Figure 1) [17]. Blood from the DNBC women was collected
around gestation week (GW) 10 and 25 as well as from the umbilical cord at birth (referred to as blood
sample (BS) 1, 2, and 3, respectively) [17].
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2.2. Dietary Fatty Acid Intake
At the time of signing informed consent (GW 6–10), the women also answered questions about
their use of drugs and dietary supplements during the peri-conceptional period, providing information
on up to eight different drugs and supplements. Telephone interviews (TI) were scheduled to be
undertaken in GW 12 and GW 30. The women completed a comprehensive FFQ with approximately
360 food items in GW 25–26, which captured foods and beverages consumed in the past four weeks [18].
Central food items in the LCn3FAs intake calculation include seafood cold cuts (12 types) and warm
meals with seafood (14 types). Some important contributors to ALA, LA, and AA were plant oils
and margarines for cooking and as spread, dressings, eggs, meats, and processed foods. The most
commonly used plant oils used for cooking in the DNBC included sunflower, olive, and grapeseed oil.
Intake in grams or milligrams per day for all fatty acids was computed based on the FFQ-reported
daily intake frequencies of food items multiplied by predefined portion sizes, followed by nutrient
calculations by use of Danish nutrient tables developed and continuously updated by the National Food
Institute at the Technical University of Denmark [19]. In addition to dietary intake, the FFQ collected
information on dietary supplementation by open-ended questions, which allowed an indication of
adherence of and details on up to six different dietary supplements taken during pregnancy, including
product name, nutrient content, and dosage.
2.3. Plasma Fatty Acid Concentration
Comprehensive plasma fatty acid concentration analyses of EPA, DHA, ALA, LA, and AA from
BS1 and BS2 were conducted at the Nutritional Biomarker laboratory at Harvard T. H. Chan School
of Public Health (HSPH) from January to November 2015. The samples for the present study were
frozen and stored at−30 ◦C at first, and in 2013 allocated to either−20 (3.6%), −80 (15.9%), or−196 ◦C
(82.6% of samples) freezers in the Danish National Biobank [17]. Primarily, we aimed to compare
FFQ-data with BS2, since it was drawn at mid pregnancy where the FFQ was filled out. If BS2
was missing and BS1 from GW 10 was available, BS1 was used instead (1.5%). Fatty acids were
extracted and prepared for analysis by transmethylation, using methanol and sulfuric acid as described
previously [20,21]. Following esterification, the fatty acid methyl esters were suspended in iso-octane
and quantitated by gas-liquid chromatography as fully described by Baylin et al. [10]. The fatty acid
measurements represented the complete spectrum of plasma lipid fractions, including triacylglycerol,
cholesterol esters, phospholipids, and free fatty acids (including albumin-bound free fatty acids).
Quality control in the HSPH laboratory is maintained by external validation through participation in
programs offered by both the American Oil Chemists Society and the National Institute of Standards
and Technology. EPA, DHA, ALA, LA, and AA have within-run coefficients of variation of 2%, 2%, 1%,
1%, and 2%, respectively. The between-run coefficients of variation for the fatty acids are 7%, 11%, 4%,
2%, and 6%, respectively.
A randomly selected control group of 345 women analyzed in relation to a previous case-control
study nested in DNBC [22]. We excluded women with missing FFQ-data (n = 79), women reporting the
use of fish oil supplements (n = 10), and one woman with an unrealistic linoleic acid intake (78 g/day)
(Figure 2).
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2.4. Statistical Analyses
Data was analyzed with the SAS software package (version 9.4; SAS Institute Inc., Cary, NC, USA)
and the statistical analysis plan was defiend a priori. We used 0.05 as the cut-off value for statistical
significance. Preliminary testing for linearity and homoscedasticity was done using scatterplots and
testing the variable assumption of normal distribution was done using histograms and QQ-plots.
Population characteristics were evaluated by univariate descriptive statistics.
EPA and DHA data was analyzed individually as well as an aggregated EPA and DHA variable,
from this point referred to as “EPA + DHA”. ALA, LA, and AA were analyzed individually. In the
primary analysis, the dietary intake of fatty acids was expressed as absolute daily intake/day. Plasma
fatty acid concentrations were expressed as a percentage of total plasma fatty acids (%TPFA) in plasma.
We conducted multivariable linear regression analyses to examine the association between dietary
intake and the plasma biomarkers of the fatty acids. The intake variable was computed as explanatory
and the biomarker variable as the response variable in these models. EPA and DHA are statistically
evaluated and presented as 100 mg/day, ALA and LA as g/day, and AA as 10 mg/day to obtain
intuitively interpretable results according to typical daily intakes. In addition, an adjusted model
was computed to account for potential interfering covariates identified a priori from the literature [8].
Covariates included age, body mass index (BMI), parity, smoking, and total energy intake. Some
women were excluded (total of 5.5%) from the adjusted analyses due to missing data (for age, BMI,
parity and smoking 0.4%, 5.1%, 4.3% and 0.4%, respectively). In order to compare with previous
studies, we performed correlation analyses, as this is the most frequently reported estimate, from
similar published studies. Depending on the nature of the variables, the non-parametric test Spearman
correlation (for EPA, DHA, and LA) or the parametric test Pearson correlation (for ALA and AA)
statistics was applied.
2.5. Secondary Analyses
As ALA was expected to contribute to some of the plasma content of EPA and DHA due to
endogenous conversion, we stratified the women by intakes higher and lower than the cohort’s
median in FFQ-based ALA intake. In the supplementary analyses, we applied the relative intake of
specific fatty acids (percentage of total intake of fatty acids) instead of absolute intake of fatty acids
(g/day) to investigate the effect of total fat intake. Moreover, we evaluated the implication of higher
storage temperatures than −196 ◦C during the last 2 years by excluding samples stored at −20 ◦C and
−80 ◦C and samples with missing temperature.
The study was conducted in accordance with the Declaration of Helsinki, and all study procedures
were approved by the Regional Scientific Ethics Committee for the municipalities of Copenhagen on
27 August 2013 (H-2-2013-108).
3. Results
Most women were primiparous, non-smokers, had high school or higher level of education,
and consumed a typical Danish diet in terms of energy intake and macronutrients composition [23]
(Table 1).
Median intakes of EPA and DHA were estimated to 0.10 and 0.26 g/day, respectively. Median
intakes of ALA, LA, and AA were 2.06, 9.81, and 0.08 g/day, respectively. Plasma concentrations of EPA
and DHA were 0.45 and 1.53%TFPA, respectively. For ALA, LA, and AA the plasma concentrations
were 0.58, 19.86, and 3.08%TFPA, respectively (Table 1).
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Table 1. Characteristics of participants at enrollment and dietary intake at mid pregnancy (n = 255).
Age, years 29.5 (4.4)
BMI, kg/m2 23.2 (4.2)
Parity, n (%)
0 children 118, 51%
1 child 84, 36%
≥2 children 30, 13%
Smoking, n (%)
Non-smoker 177, 70%
Occasional smoker 26, 10%
Daily smoker <15 cigarettes/day 43, 17%
Daily smoker ≥15 cigarettes/day 8, 3%
Education, n (%) 201
10th grade or less 53, 26%
High school similar or more 140, 70%
Dietary intake
Total energy intake, kJ/day 10,210 (2550)
Carbohydrate, % energy 51.8 (5.9)
Fat, % energy 32.6 (6.3)
Protein, % energy 15.2 (2.5)
Alcohol, % energy 0.4 (0.5)
EPA, g/day 0.10 (0.12) *
DHA, g/day 0.26 (0.25) *
EPA + DHA, g/day 0.37 (0.35) *
ALA, g/day 2.06 (1.17) *
LA, g/day 9.81 (4.36) *
AA, g/day 0.08 (0.06) *
Plasma biomarker (%TPFA)
EPA 0.45 (0.21)
DHA 1.53 (0.55)
EPA + DHA 1.99 (0.73)
ALA 0.58 (0.15)
LA 19.86 (3.12)
AA 3.08 (1.02)
Presented as number, % for categorical variable and mean (sd) for continuous variables unless otherwise indicated.
A random sample of pregnancies from the Danish National Birth Cohort (n = 243). * =Median (IQR)AA: arachidonic
acid; ALA: α-linolenic acid; BMI: body mass index; DHA: docohexaenoic acid; EPA: eicosapentaenoic acid; IQR:
inter quartile range; LA: linoleic acid; %TPFA: percentage of total plasma fatty acids.
Linear regression of the biomarker concentration on estimated intake resulted in adjusted
differences in plasma concentration of 0.05 (95% CI: 0.02; 0.08) and 0.05 (95% CI: 0.01; 0.08) %TPFA per
100 mg/day greater intake of EPA and DHA, respectively (Table 2). The unadjusted relationship is
illustrated in Figure S1.
Estimated ALA intake showed a weak association with the plasma biomarker that was
pronouncedly strengthened when adjusting for covariates in the linear regression model. This resulted
in a difference in ALA concentration of 0.07 (0.03; 0.10) %TPFA per 1 g/day greater ALA intake.
ALA intake did not correlate with EPA+DHA plasma concentrations (p = 0.42, Spearman correlation).
Estimated intakes of LA and AA did not correlate with their corresponding plasma biomarkers
(Table 2).
Nutrients 2019, 11, 568 6 of 11
Table 2. Difference in biomarker concentration (%TPFA) per increase in daily intake and correlations
between biomarker concentration and intake from Spearman statistics unless indicated otherwise
(n = 255).
Regression Coefficients (95% CI) from Linear Regressions
Correlation
CoefficientsNon-Adjusted Adjusted for Age, Parity, BMI,Smoking, and Total Energy Intake
EPA 0.05 (0.02; 0.08) % per 100 mg/day ** 0.05 (0.02; 0.08) % per 100 mg/day * 0.24 ***
DHA 0.05 (0.01; 0.08) % per 100 mg/day * 0.05 (0.01; 0.08) % per 100 mg/day * 0.18 *
EPA + DHA 0.05 (0.02; 0.08) % per 100 mg/day * 0.05 (0.02; 0.08) % per 100 mg/day * 0.21 **
ALA 0.03 (0.01; 0.05) % per 1 g/day 0.07 (0.03; 0.10) % per 1 g /day ** 0.15 a
LA 0.10 (−0.01; 0.22) % per 1 g/day 0.17 (−0.04; 0.38) % per 1 g/day 0.08
AA 0.01 (−0.02; 0.03) % per 10 mg/day 0.02 (−0.01; 0.04) % per 10 mg/day 0.05 a
BOLD = p < 0.05, * = p < 0.01, ** = p < 0.001, *** = p < 0.0001. a Pearson correlation. AA: arachidonic acid; ALA:
α-linolenic acid; BMI: body mass index; DHA: docohexaenoic acid; EPA: eicosapentaenoic acid; LA: linoleic acid;
%TPFA: percentage of total plasma fatty acids.
When stratifying according to estimated intake of ALA (below or above the median intake of
2.06 g/day) (Table 3), women with low ALA intakes tended to have stronger correlations between
intakes and plasma biomarkers of EPA and DHA compared to the women with high intakes of ALA.
(Table 3).
Table 3. Difference in biomarker concentration (%TPFA) per increase in daily intake and correlations
between biomarker concentration and intake from Spearman statistics unless indicated otherwise.
Regression Coefficients (95% CI) from Linear Regressions
Correlation
CoefficientNon-Adjusted Adjusted for Age, Parity, BMI,Smoking and Total Energy Intake
EPA
≥2.06 g/day ALA 0.05 (0.01; 0.09) % per 100 mg/day 0.05 (0.01; 0.09) % per 100 mg/day 0.18
<2.06 g/day ALA 0.06 (0.02; 0.11) % per 100 mg/day * 0.05 (0.01; 0.10) % per 100 mg/day * 0.33 **
DHA
≥2.06 g/day ALA 0.03 (−0.02; 0.07) % per 100 mg/day 0.02 (−0.02; 0.07) % per 100 mg/day 0.09
<2.06 g/day ALA 0.09 (0.04; 0.15) % per 100 mg/day * 0.09 (0.03; 0.14) % per 100 mg/day * 0.27 *
EPA + DHA
≥2.06 g/day ALA 0.03 (−0.01; 0.07) % per 100 mg/day 0.03 (−0.01; 0.07) % per 100 mg/day 0.12
<2.06 g/day ALA 0.08 (0.03; 0.14) % per 100 mg/day * 0.08 (0.03; 0.13) % per 100 mg/day * 0.29 **
Stratified analyses according to dietary ALA-above (n = 128) and below (n = 127) median intake of ALA (2.06 g/day).
BOLD = p < 0.05, * = p < 0.01, ** = p < 0.001. AA: arachidonic acid; ALA: α-linolenic acid; DHA: docohexaenoic acid;
EPA: eicosapentaenoic acid; LA: linoleic acid; %TPFA: percentage of total plasma fatty acids.
When expressing the intake of specific fatty acids as percentage of total fatty acid intake (Table S1)
instead of absolute intake (Table 2), the correlation coefficient increased for DHA, which is also
demonstrated by lower p-value in the unadjusted linear regression coefficient. For ALA, this weakened
the strength of correlation to less than significance level. LA and AA, expressed as percentage of total
fatty acid intake, remained insignificant in their association with biomarkers (Table S1).
Both EPA and DHA correlations were somewhat weakened when we restricted the analysis
to samples stored at −196 ◦C, thus excluding samples stored at −20 ◦C and −80 ◦C and missing
temperatures (n = 52 excluded), but the overall associations tended to be retained for these fatty acids.
This stratification did not change the correlations for ALA, LA, and AA (Table S2a,b).
4. Discussion
In this study, we demonstrated moderate but consistent correlations between FFQ-based
dietary intake estimates of EPA and DHA and the corresponding plasma biomarker concentrations.
The associations tended to get stronger when restricting the analysis to women with low intake of
ALA. We found a weak correlation between the dietary intake of ALA and its plasma biomarker, while
dietary intake of LA and AA failed to correlate with the corresponding plasma biomarkers.
EPA and DHA—Our results are generally in accordance with previous findings in non-pregnant,
addressing the relationship between self-reported intake of EPA and DHA from any type of assessment
Nutrients 2019, 11, 568 7 of 11
method: FFQs, food diaries or records, interviews, and biomarkers of EPA and DHA from various
body tissues [8,9]. Published correlation coefficients applying the same combination of data sources
(FFQ and biomarkers in plasma) range from r = 0.23 in a Costa Rican population (n = 200) [10] to
r = 0.54 in an Australian population (n = 53) for total n-3 fatty acids [24]. Within these extremes,
many intermediate estimates have been reported [11–15,24,25]. In addition to the varying population
sizes, the discrepancy in correlation strength possibly arises from differences in FFQ quality as well
as in lifestyle, that is, ranges of intake and genetic as well as metabolic characteristics between the
populations. Additionally, the choice of biomarker tissue, lipid fractions, sample processing, fatty acid
separation, and quantification technique might also contribute to the between-study differences.
Conceptually, it is reasonable to believe that metabolic changes in pregnancy can disrupt the
normal relationship between intake and plasma levels of fatty acids, which challenges comparison
of present results with previous validation studies in non-pregnant populations. As an example,
circulating estrogen is increased during pregnancy, and estrogen is known to stimulate DHA
synthesis [26]. Furthermore, in contrast to adipose tissue, plasma is affected by metabolic variation
between individuals such as the levels of HDL, LDL, and VLDL in plasma, since they contain different
proportions of the fatty fractions: triglycerides, cholesterol esters, and phospholipids which in turn will
have distinct fatty acid compositions [8]. During pregnancy, increases in LDL and VLDL are commonly
observed [27], which could possibly differentiate present results from other validation studies based
on non-pregnancy cohorts. Furthermore, the challenge of reporting error may be more pronounced
in pregnant women as dietary habits are expected to be more dynamic due to pregnancy-related
behavioral changes [28].
Dietary habits including total fat intake might play a role in the diet–biomarker relationship [8].
In the present study, total fat intake was indirectly accounted for by expressing the intake variable
as percentage of total fat intake and this maintained a correlation between LCn3FAs intakes and
their biomarkers with strengthened correlation for DHA. Another important source to between-study
variation is differences in between-person variation in LCn3FA intake across studies, which, if large,
gives rise to stronger diet-biomarker association correlation coefficients [10,14]. This phenomenon
is reflected in results from a Japanese cohort, reporting a median consumption of around four times
the EPA and DHA intake in DNBC [29]. The higher intake among Japanese participants gives rise
to greater variability in absolute intake than for DNBC, which might have contributed to the strong
intake–biomarker correlations of r = 0.43 and r = 0.35 for EPA and DHA, respectively [29]. The intake
estimate of 0.37 g EPA+DHA per day among DNBC women is low compared to previous estimations
within the Danish population. Intake estimates of EPA+DHA deriving from 7-day weighted food
records from women (n = 63) and 7-day food record from women and men (n = 24) have been
determined to approximately 0.5 g/day in both studies [30,31].
High or low consumption of other fatty acids from the n-3 and n-6 families may have affected the
investigated correlations [32]. The process of transforming n-3 fatty acids into the long-chained fatty
acids EPA and DHA is highly dependent on the accessibility of ALA, since it serves as substrate for
endogenous LCn3FAs synthesis. Therefore, a low ALA intake is expected to limit the formation of
EPA and DHA and vice versa. In line with the theory, we observed that the women with a low intake
of ALA had a stronger correlation for both EPA and DHA compared to women with a high intake.
Interestingly, and as also reported by others, EPA correlated better with its corresponding biomarker
than DHA, which might be explained by binding affinity differences between the two fatty acids in the
chylomicron-dependent transport to the liver following absorption [32].
Plasma lipids may have been affected by several non-dietary factors, some of which we were able
to adjust for in the regression models. In addition to the covariates included in the adjusted model (age,
parity, BMI, smoking, and total energy intake), we know from previous literature that other modifiable
and likely pregnancy-dependent factors including sex hormones and exercise can influence plasma
levels of LCn3FAs [8]. Genetic differences might also contribute to the between-study differences in
diet–biomarker correlations. Genes coding for proteins involved in uptake, metabolism, transport and
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restructuration, especially the FADS gene cluster, which is related to desaturation steps in the n-3 and
n-6 fatty acids, could potentially differentiate the DNBC women from other study populations [8].
ALA, LA, AA—While a correlation between FFQ-reported intake and plasma biomarkers of EPA
and DHA is well established, it remains more speculative for the remaining members of the PUFA
family. It seems plausible that higher availability of the n-6 family fatty acids in plasma compared to
n-3 family fatty acids makes endogenous conversion, restructuring to other fat fractions or spillover
to other body compartments more pronounced for the n-6 family [8]. Such endogenous dynamics of
ALA, LA, and AA challenge the use of biomarkers to reflect dietary intake and may have played an
important role in the weak correlations observed. Previous results, however, demonstrate a marked
variation in intake and biomarker correlation for LA and generally low to moderate correlation for
ALA and poor correlation for AA [8].
Limitations in the self-reported dietary intake, technical errors in the plasma measurements,
or actual between-individual differences in the study population might play a role in the lack of
correlation between estimated dietary intake and biomarker level. It is most likely a function of all
three, but what clearly differentiates the results on ALA, LA and AA from those on EPA and DHA is
the greater difficulty in dietary intake assessment. EPA and DHA are found in high concentrations in a
limited number of foods of marine origin, and which therefore can be assessed by a FFQ with relatively
few food items. The long list of dietary sources of ALA, LA hereunder the cooking oils (sunflower,
olive and grapeseed oil) used by DNBC women and the various animal products containing AA make
assessment accuracy highly dependent on the quality and coverage of the FFQ and the reporting
performance. For these foods, the nutritional composition, serving size, and frequency of intake are
difficult to determine by a FFQ.
Plasma LA levels has previously been reported to be a valid biomarker of dietary LA intake
in the Costa Rican study (r = 0.41) [10]. In the Costa Rican cohort, much effort has been allocated
to biochemical assessment of the fatty acid composition of the actual oil product consumed, which
may have yielded a higher accuracy of the reported dietary intake of LA compared to our data.
The DNBC FFQ captured the intake of plant oils by addressing oils used for cooking and frying
and in dressings/spreads, but not as comprehensively as in the Costa Rican cohort study. This
could indicate that the FFQ’s inaccuracy in capturing LA intake could be the driver of the weak LA
correlation observed.
There is an ongoing debate about which biological tissue provides the fatty acid biomarkers
that best represent dietary intake. Adipose tissue is commonly used and generally considered the
best tissue to reflect long-term dietary intake [9] but might not be appropriate to reflect more recent
intake. Previous evaluation found that LCn3FA levels in plasma correlate well with adipose tissue
levels [10]. Furthermore, albeit with weaker correlation than for fatty acids in adipose tissue, plasma
fatty acids have previously been demonstrated to correlate well with FFQ-derived dietary intake [10].
We analyzed total lipid fractions in plasma, which include phospholipids, triglycerides, cholesterol
esters, and free fatty acids. Since some fractions reflect long-term dietary intake while others reflect
short-term fluctuations in the diet, it will limit the temporal specificity of the measurement, and might
not reflect same time window as the FFQ. Free fatty acids in plasma have previously been shown
to correlate well with the long-term fatty acid biomarkers from subcutaneous adipose tissue, while
phospholipids and cholesterol esters reflect the previous week’s intake and triglycerides reflect the
fatty acid composition of the latest meal [8]. However, other experimental studies show that there are
no differences between triglycerides, cholesterol esters, and phospholipids in response to short-term
increases in fatty acid intake [32,33], indicating that it is still a subject of controversy. Another concern
in present study is the non-fasting state of the women when samples were drawn. However, several
studies show minimal effect of fasting, and a recent evaluation from European Federation of Clinical
Chemistry and Laboratory Medicine suggests non-fasting samples as the new standard medium for
lipid measurement [34].
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5. Conclusions
In summary, our findings suggest that the DNBC FFQ adequately quantifies DHA and EPA
intakes in Danish pregnant women, supporting their use in future diet–disease association studies
within DNBC. We found a weak correlation between ALA intake estimate and its biomarkers, and no
correlation for LA and AA. Whether this is caused by poor validity of the intake estimates or by
biologically-based variability between intake and plasma levels is yet to be investigated. Noticeably, our
results are specific for pregnant women, who might differ from other non-pregnant study populations.
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